U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579962) titled 'Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)' on April 22.
Brief Summary: In biomedical applications, electroporation is used not only for cancer treatment but also for vaccinations, treatment of cardiac arrhythmias and, more recently, for the treatment of vascular malformations. Bleomycin is a frequently used sclerosing agent in the treatment of various vascular malformations. The use of electrical pulses in addition to bleomycin increases the effectiveness of the treatment, similar to electrochemotherapy. Bleomycin electrosclerotherapy (BEST) is a new treatment modality that is effective i...